• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 7:12:46 AM ET
    $CCM
    Medical/Nursing Services
    Health Care
    Get the next $CCM alert in real time by email
    SC 13G/A 1 tm216734d1_sc13ga.htm SCHEDULE 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

    ——————————————

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

    ——————————————

     

     

    Concord Medical Services Holdings Limited

    (Name of Issuer)

     

     

    Class A Ordinary Shares

    (Title of Class of Securities)

     

     

    206277 1051

    (CUSIP Number)

     

     

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)

     

    xRule 13d-1(c)

     

    ¨Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    1This CUSIP number applies to the American depositary shares (the “ADSs”) of the Issuer (as defined below), each representing three Class A Ordinary Shares, par value US$0.0001 per share, of the Issuer (as defined below).

     

     

     

     

    CUSIP Number: 206277 105

     

    1

    Names of Reporting Persons

     

    Sirong Tian

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ¨

    (b) ¨

     

    3

    SEC Use Only

     

     

    4

    Citizenship or Place of Organization

     

    Hong Kong

    Number of Shares Beneficially Owned by Each Reporting Person with 5

    Sole Voting Power

     

    15,379,303 Class A Ordinary Shares1

    6

    Shared Voting Power

     

    0

    7

    Sole Dispositive Power

     

    15,379,303 Class A Ordinary Shares1

    8

    Shared Dispositive Power

     

    0

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    15,379,303 Class A Ordinary Shares1

    10

    Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

    ¨

     

    11

    Percent of Class Represented by Amount in Row (9)

     

    18.2%1

    12

    Type of Reporting Person (See Instructions)

     

    IN

     

     

    1Represents 14,163,325 Class A Ordinary Shares and 405,326 ADSs, each representing three Class A Ordinary Shares, held by Solar Honor Limited, a limited liability company organized under the laws of British Virgin Islands wholly owned by Ms. Tian (as defined below). Percentage is calculated based on 84,454,047 Class A Ordinary Shares issued and outstanding as of April 30, 2020, which was disclosed in the Issuer’s annual report on Form 20-F (File No. 001-34563) filed with the Securities and Exchange Commission (the “SEC”) on April 30, 2020 (the “Form 20-F”).

     

     

     

    CUSIP Number: 206277 105

     

    1

    Names of Reporting Persons

     

    Solar Honor Limited

    2

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ¨

    (b) ¨

     

    3

    SEC Use Only

     

     

    4

    Citizenship or Place of Organization

     

    British Virgin Islands

    Number of Shares Beneficially Owned by Each Reporting Person with 5

    Sole Voting Power

     

    15,379,303 Class A Ordinary Shares1

    6

    Shared Voting Power

     

    0

    7

    Sole Dispositive Power

     

    15,379,303 Class A Ordinary Shares1

    8

    Shared Dispositive Power

     

    0

    9

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    15,379,303 Class A Ordinary Shares1

    10

    Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

    ¨

     

    11

    Percent of Class Represented by Amount in Row (9)

     

    18.2%1

    12

    Type of Reporting Person (See Instructions)

     

    CO

     

     

    1Represents 14,163,325 Class A Ordinary Shares and 405,326 ADSs. Percentage is calculated based on 84,454,047 Class A Ordinary Shares issued and outstanding as of April 30, 2020, which was disclosed in the Form 20-F.

     

     

     

     

    Item 1(a).Name of Issuer:

     

    Concord Medical Services Holdings Limited (the “Issuer”)

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

    Room 2701-05, Tower A, Global Trade Center, 36 North Third Ring Road East, Dongcheng District, Beijing 100013, People’s Republic of China

     

    Item 2(a).Name of Person Filing:

     

    Sirong Tian (“Ms. Tian”)

     

    Solar Honor Limited

     

    Item 2(b).Address or Principal Business Office or, if None, Residence:

     

    Sirong Tian

    Room 303, No.3, Lane 708, Lingshan Road, Pudong New District, Shanghai, China

     

    Solar Honor Limited

    Unit 8, 3/F., Qwomar Trading Complex, Blackburne Road, Port Purcell, Road Town, Tortola, British Virgin Islands

     

    Item 2(c).Citizenship or Place of Organization:

     

    Sirong Tian – Hong Kong

     

    Solar Honor Limited – British Virgin Islands

     

    Item 2(d).Title of Class of Securities:

     

    Class A Ordinary Shares, par value US$0.0001 per share (“Class A Ordinary Shares”)

     

    Item 2(e).CUSIP Number:

     

    There is no CUSIP number assigned to the Class A Ordinary Shares. CUSIP number 206277 105 has been assigned to the ADSs, which are quoted on The New York Stock Exchange under the symbol “CCM.” Each ADS represents three Class A Ordinary Shares.

     

    Item 3.If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

     

    Not applicable.

     

    Item 4.Ownership.

     

    The following information with respect to the ownership of the Class A Ordinary Shares by the reporting persons filing this statement is provided as of December 31, 2020. Percentages are calculated based on 84,454,047 Class A Ordinary Shares issued and outstanding as of April 30, 2020, which was disclosed in the Form 20-F, and with respect to each reporting person, including the Class B Ordinary Shares (as defined below) that such reporting person beneficially owned and convertible into Class A Ordinary Shares, and the Class A Ordinary Shares that such reporting person has the right to acquire within 60 days of December 31, 2020.

     

     

     

     

               Number of Class A Ordinary Shares as to which the Person has: 
    Reporting Person 

    Amount
    Beneficially
    owned

      

    Percent
    of Class

      

    Sole
    Voting
    Power

      

    Shared
    Voting
    Power

      

    Sole
    Dispositive
    Power

      

    Shared
    Dispositive
    Power

     
    Sirong Tian   15,379,303    18.2%   15,379,303    —    15,379,303    — 
    Solar Honor Limited   15,379,303    18.2%   15,379,303    —    15,379,303    — 

     

    As of December 31, 2020, Solar Honor Limited directly owned 15,379,303 Class A Ordinary Shares, consisting of 14,163,325 Class A Ordinary Shares and 405,326 ADSs, each representing three Class A Ordinary Shares. Sirong Tian is the sole shareholder and the sole director of Solar Honor Limited.

     

    As of December 31, 2020, Ms. Tian, through Model Oasis Limited, a limited liability company organized under the laws of the British Virgin Islands wholly owned by her, indirectly held 30% of equity interest in Morgancreek Investment Holdings Limited (“Morgancreek”), a limited liability company organized under the laws of the British Virgin Islands, which held 38,287,948 Class B ordinary shares, par value US$0.0001 per share, of the Issuer (“Class B Ordinary Shares”), each convertible into one Class A Ordinary Share, and 4,660,976 ADSs, each representing three Class A Ordinary Shares. Ms. Bi Zhang, the spouse of the chairman and chief executive officer of the Issuer, indirectly held 70% of equity interest in Morgancreek. Dr. Jianyu Yang, the chairman and chief executive officer of the Issuer, is the sole director of Morgancreek and has the power to direct Morgancreek as to the voting and disposition of the Class B Ordinary Shares and the ADSs held by Morgancreek. Accordingly, Ms. Tian disclaimed her beneficial ownership in all the Class B Ordinary Shares and the ADSs representing Class A Ordinary Shares held by Morgancreek.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6.Ownership of More Than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

     

    Not applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.Certifications.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 16, 2021

     

      Sirong Tian  
         
      /s/ Sirong Tian  
         
         
      Solar Honor Limited  

     

      By: /s/ Sirong Tian  
      Name: Sirong Tian  
      Title: Director  

      

     

     

     

    Exhibit Index

     

     

    Exhibit No. Description
       
    99.1 Joint Filing Agreement

     

     

    Get the next $CCM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CCM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Concord Healthcare Announces Official Release of the Proton Therapy Large Model

      BEIJING, May 29, 2025 /PRNewswire/ -- Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company") (NYSE:CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK, announced that Concord Healthcare had made important progress in precise tumor diagnosis and treatment technology. Concord Healthcare's self-developed large language model ("LLM") in the vertical field of proton therapy was officially released and successfully deployed in Guangzhou Concord Cancer Hospital. Since the commencement of the proton therapy in Guangzhou Concord Cancer Hospi

      5/29/25 4:30:00 PM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • Concord Medical Files Annual Report on Form 20-F for Fiscal 2024

      BEIJING, April 25, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the audited financial statements free of charge upon request. Requests should be submit

      4/25/25 6:00:00 PM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • Concord Medical Announces Result of 2024 Annual General Meeting

      BEIJING, Jan. 6, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it held its 2024 annual general meeting of shareholders on December 27, 2024. At the meeting, the shareholders resolved by special resolution that amended and replaced the Fourth Memorandum and Articles of Association of the Company then in effect by the adoption of the Fifth Amended and Restated Memorandum and Articles of Association. About Concord Medical Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle

      1/6/25 7:30:00 AM ET
      $CCM
      Medical/Nursing Services
      Health Care

    $CCM
    SEC Filings

    See more

    $CCM
    Leadership Updates

    Live Leadership Updates

    See more

    $CCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $CCM
    Financials

    Live finance-specific insights

    See more
    • SEC Form 6-K filed by Concord Medical Services Holdings Limited

      6-K - Concord Medical Services Holdings Ltd (0001472072) (Filer)

      6/4/25 7:30:34 AM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • SEC Form 6-K filed by Concord Medical Services Holdings Limited

      6-K - Concord Medical Services Holdings Ltd (0001472072) (Filer)

      5/29/25 4:46:22 PM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • SEC Form 6-K filed by Concord Medical Services Holdings Limited

      6-K - Concord Medical Services Holdings Ltd (0001472072) (Filer)

      5/29/25 4:01:22 PM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • Concord Medical Announces Divestment of Singapore Concord International Hospital

      BEIJING, Dec. 28, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that the Company has, through its subsidiaries, entered into a definitive agreement to sell 90% equity interest in Concord Healthcare Singapore Pte Ltd, which operates and owns a general medical and surgical hospital, namely Concord International Hospital ("CIH"), for a total consideration of approximately SG$52.2 million. The p

      12/28/20 6:47:00 AM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - Concord Medical Services Holdings Ltd (0001472072) (Subject)

      2/16/21 7:12:46 AM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • Concord Medical Reports Financial Results for the First Half of 2024

      BEIJING, Sept. 27, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2024[1]. 2024 First Half Highlights Total net revenues were RMB218.8 million (US$30.1 million) in the first half of 2024, representing a 23.1% decrease from total net revenues of RMB284.5 million in the same period last year. Total net revenues included the net revenues from the hospital business of RMB137.8 million (US$19.0 million) and the net revenues from the network

      9/27/24 7:00:00 AM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • Concord Medical Reports Financial Results for the First Half of 2023

      BEIJING, Sept. 22, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023[1]. 2023 First Half Highlights Total net revenues were RMB284.5 million (US$39.2 million) in the first half of 2023, representing a 97.2% increase from total net revenues of RMB144.3 million in the same period last year. Total net rev

      9/22/23 5:00:00 PM ET
      $CCM
      Medical/Nursing Services
      Health Care
    • Concord Medical Reports Financial Results for the First Half of 2022

      BEIJING, Sept. 23, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2022[1]. 2022 First Half Highlights Total net revenues were RMB144.3 million (US$21.5 million) in the first half of 2022, representing a 25.2% decrease from total net revenues of RMB192.9 million in the same period last year. Total net reve

      9/23/22 4:00:00 PM ET
      $CCM
      Medical/Nursing Services
      Health Care